NRBO
NeuroBo Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website neurobopharma.com
- Employees(FY) 2
- ISIN US64132R4048
Performance
+16.65%
1W
+37.06%
1M
-11.57%
3M
+36.1%
6M
+26.06%
YTD
+1.3%
1Y
Profile
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
Technical Analysis of NRBO 2024-05-10
Overview:
In analyzing the technical indicators for NRBO over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2024-05-09 01:53
- 2024-05-08 20:01
- 2024-04-29 20:01
- 2024-04-16 20:05
- 2024-03-31 20:01
- 2024-03-27 20:01
- 2024-03-12 20:01
- 2024-03-03 19:01
- 2024-02-28 19:01
- 2024-02-11 19:01
- 2024-01-31 19:01
- 2024-01-17 19:01
- 2024-01-08 19:30
- 2024-01-01 19:01
- 2023-12-27 19:45
- 2023-12-18 19:43
- 2023-12-14 19:35
- 2023-12-12 00:02
- 2023-11-30 19:31
- 2023-11-13 03:05
- 2023-11-05 19:05
- 2023-10-16 20:01
- 2023-09-14 20:01
- 2023-08-13 20:01
- 2023-08-09 04:05
- 2023-08-02 20:01
- 2023-08-01 20:01
- 2023-06-26 20:01
- 2023-06-12 20:01
- 2023-05-11 20:00
Page 1 of 3
previousnext